Croma Lifescience Private Limited - Due diligence report

A 360° intelligence report on Croma Lifescience Private Limited: trust score, financial health, credit view, compliance, directors, growth a…

2011-12-26 Pipli, Gujarat Active Unlisted Active Compliant
Share
Connect MCP
CL Croma Lifescience Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Croma Lifescience Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Croma Lifescience Private Limited is assessed as Low Risk with a Trust Score of 76/100. Croma Lifescience Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Croma Lifescience Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
45/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).

Charges position: 1 open (2.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Bank Of Baroda1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
MALABHAI MAKANBHAI KANZARIYA 01234567 Director 01/04/2018 6 yrs Approved
Arvind Naran Kagathara 01234567 Director 01/04/2018 6 yrs Approved
ALPESHKUMAR PRABHULAL FEFAR 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
8 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 45 · Distress 50
Growth signals & trust indicators
Asset base grew 2.1x - capacity expansion.
Operating for 14+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Outside liabilities up 24% in a year.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence78/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment56/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 2.00 cr already registered.
  • Compliance record supports lending.
Investor view53/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Apr 2024
Director appointed
Arvind Naran Kagathara (Director)
Director ceased
JAYDEEP SHANTILAL VIDJA
29 Aug 2020
Director ceased
SHANTILAL DHARAMSHIBHAI FEFAR
26 Jun 2020
Director appointed
MALABHAI MAKANBHAI KANZARIYA (Director)
27 Jul 2017
Director ceased
JAYESHKUMAR CHATURBHAI DADHANIYA
16 Oct 2014
Securities allotted
390000 Equity Shares Without Differential Rights - 39.00 Lakh raised
31 Mar 2014
Securities allotted
390000 Equity Shares Without Differential Rights - 39.00 Lakh raised
07 Feb 2013
Securities allotted
402300 Equity Shares Without Differential Rights - 40.23 Lakh raised
01 Feb 2013
Securities allotted
402300 Equity Shares Without Differential Rights - 40.23 Lakh raised
23 Dec 2012
Securities allotted
398000 Equity Shares Without Differential Rights - 39.80 Lakh raised
21 Nov 2012
Securities allotted
398000 Equity Shares Without Differential Rights - 39.80 Lakh raised
05 Aug 2012
Securities allotted
619700 Equity Shares Without Differential Rights - 61.97 Lakh raised
02 Aug 2012
Securities allotted
619700 Equity Shares Without Differential Rights - 61.97 Lakh raised
10

Key Observations

Auto-generated from the data above
Revenue declined 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
Capital has been raised through 8 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Medi-Vesp Pharma Private Limited U36100MH2013PTC250045 Mumbai, Maharashtra, India
Impress Chemicals Private Limited U40100MP2004PTC016830 Indore, Madhya Pradesh, India
Creole Chemtech Private Limited U24304UR2017PTC007943 Kashipur, Uttarakhand, India
Bamer Bio India Private Limited U24290TG2019PTC136418 Hyderabad, Telangana, India
Karma Koncept Lifestyle Private Limited U52190RJ2015PTC047689 Jaipur, Rajasthan, India
Mothertree Nutra Private Limited U74999PN2018PTC177945 Midc Kudal Kudal, Maharashtra, India
Brahmanath Pharma Private Limited U24100MH2015PTC271264 Panvel, Maharashtra, India
Surfacelabs India U74999KA2018PTC119229 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Croma Lifescience Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Croma Lifescience Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 45/100, margin trends, ownership structure and peer set for Croma Lifescience Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Croma Lifescience Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Croma Lifescience Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Croma Lifescience Private Limited an active company?

Croma Lifescience Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Croma Lifescience Private Limited financially healthy?

Croma Lifescience Private Limited has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Croma Lifescience Private Limited?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Croma Lifescience Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Croma Lifescience Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Croma Lifescience Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Croma Lifescience Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.